Cleavage of α-sunuclein by Neurosin (Kallikrein-6)
Cleavage of α-sunuclein by Neurosin (Kallikrein-6)
批准号:
16590840
负责人:
MIZUNO Toshiki
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background : Neurosin (Kallikrein-6), one of the serine proteases predominantly expressed in the central nervous system, was reported to be possible to degrade α-synuclein, a key protein for Parkinson disease. However, cleavage site of α-synuclein by neurosin has not been detected. In this study, cleavage sites of α-synuclein were identified by LC/MS/MS.Method : Degradations of wild and mutant α-synuclein by neurosin were evaluated semi-quantitatively by SDS-PAGE. Restricted fragments of α-synuclein cleaved by neurosin were examined by LC/MS/MS (Ion trap mass spectrometer ; LCQ Advatage, Themo Electron Corporation, Waltham, MA).Results : The first cleaving site of α-synuclein was Lyn80, and secondly Lyn96, Lyn97, Asp115 and Asp121 were cleaved by neurosin. A30P mutant α-synuclein was degraded slower than wild α-synuclein by neurosin.Interpretation : The dominant cleaving site of Lyn80 is the center of the NAC region, which is responsible for polymerization of the α-synuclein. Our results showed that neurosin can degrade α-synuclein and it may inhibit the polymerization of α-synuclein by cleaving the NAC region.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Quantitative evaluation of cerebrovascular reactivity in brain tissue by a refill kinetic method of transcranial ultrasonic perfusion imaging : a comparison with Doppler sonography
经颅超声灌注成像再填充动力学法定量评估脑组织脑血管反应性:与多普勒超声检查的比较
DOI:
--
发表时间:
2005
期刊:
Acta Neurochir 95(suppl)
影响因子:
--
作者:
[T.Shiogai, A.Morisaka, N.Takayasu, K.T.Mizuno, et al.]
通讯作者:
et al.
Discrepancy between clinical and pathological diagnoses of CBD and PSP.
CBD 和 PSP 的临床和病理诊断之间的差异。
DOI:
--
发表时间:
2005
期刊:
J Neurol 252・6
影响因子:
--
作者:
[Mizuno T, Shiga K, Nakata Y, Nagura J, Nakase T, Ueda Y, Takanashi Y, Urasaki K, Oyamada Y, Fushiki S, Nishikawa J, Yasuhara M, Nakajima K, Nakagawa M.]
通讯作者:
Nakagawa M.
DOI:
10.1016/j.autneu.2005.09.004
发表时间:
2005-12-30
期刊:
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
影响因子:
2.7
作者:
[Kuriyama, N, Mizuno, T, Nakagawa, M]
通讯作者:
Nakagawa, M
DOI:
10.1007/s00415-005-0708-0
发表时间:
2005-05-01
期刊:
JOURNAL OF NEUROLOGY
影响因子:
6
作者:
[Shiga, K, Yamada, K, Nakagawa, M]
通讯作者:
Nakagawa, M
Pathomechanism of cerebral small vessel induced by TGFβ1 signalling
-
批准号:22591595
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2010
-
负责人:MIZUNO Toshiki
-
依托单位:
MOLECULAR EPIDEMIOLOGY OF APOLIPOPROTEIN E AND VITAMIN D RECEPTOR IN NORTHERN PART OF KYOTO PREFECTURE
-
批准号:07670449
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:MIZUNO Toshiki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ROS介导的α-synuclein/KLF9/PRB信号轴调控子宫内膜异位症孕激素抵抗的分子机制研究
-
批准号:2026JJ81255
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:冯力元
-
依托单位:
天麻20C通过抑制α-Synuclein聚集二次成核动力学过程发挥帕金森病治疗特色的机制研究
-
批准号:2025JJ60645
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:彭也
-
依托单位:
新型 DMC 结构类似物抗帕金森病中α
-synuclein 病理的作用机制研究
-
批准号:Z24H250003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张云龙
-
依托单位:
α-Synuclein 乳酸化修饰降低突触可塑性导致 POCD 的机制研究
-
批准号:24ZR1457700
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张辉
-
依托单位:
脾脏巨噬细胞功能失调介导血源性α-synuclein异构体清除障碍在PD发病中的机制研究
-
批准号:82301430
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:袁心
-
依托单位:
利用非人灵长类模型研究帕金森病致病蛋白α-synuclein的生理功能
-
批准号:32370567
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:杨伟莉
-
依托单位:
囊泡基质蛋白Chromogranin A调控α-synuclein异常聚集及其在帕金森病早期发病机制中的研究
-
批准号:82371426
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:吴齐辉
-
依托单位:
α-Synuclein通过抑制STUB1/TFEB介导的自噬促进肥胖相关的子宫内膜容受性下降的作用及机制研究
-
批准号:82301896
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:何晔
-
依托单位:
基于天然双四氢呋喃型木脂素结构的靶向α-synuclein聚集抑制的抗帕金森病先导化合物的发现研究
-
批准号:82373766
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚胜
-
依托单位:
红细胞来源的α-synuclein蛋白在帕金森病中的作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:金旺盛
-
依托单位: